Stockscreener 앱 받기
4.83
0.21%
0.010
시간 외 거래:
5.43
0.60
+12.42%
전일 마감가:
$4.82
열려 있는:
$4.86
하루 거래량:
1.53M
Relative Volume:
1.02
시가총액:
$612.99M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
135.29
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
+3.65%
1개월 성능:
-20.82%
6개월 성능:
+57.33%
1년 성능:
+42.06%
1일 변동 폭
$4.75
$5.00
1주일 범위
$4.605
$5.00
52주 변동 폭
$2.6101
$7.0771
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
ORGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.83 | 611.72M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
120.98 | 52.29B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.61 | 45.27B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 42.39B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.13 | 34.18B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.30 | 21.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - The Manila Times
Organogenesis to submit rolling BLA for knee osteoarthritis treatment By Investing.com - Investing.com Australia
Organogenesis stock soars after FDA meeting clears path for ReNu BLA - Investing.com
Organogenesis Holdings Inc. Initiates Rolling BLA Submission for ReNu Targeting Knee Osteoarthritis Expected by End of 2025 - Quiver Quantitative
Organogenesis announces successful FDA meeting and plan to file BLA for ReNu® - marketscreener.com
Organogenesis (Nasdaq: ORGO) to file BLA for ReNu knee OA pain by Dec. 2025 - Stock Titan
December 2025's Top Penny Stocks With Promising Potential - simplywall.st
Organogenesis: High-Tech Skin Substitute Company On Sale (NASDAQ:ORGO) - Seeking Alpha
Investors in cash trouble should check out Organogenesis Holdings Inc (ORGO) - setenews.com
Why analysts remain bullish on Organogenesis Holdings Inc. stockEarnings Beat & Technical Entry and Exit Alerts - Newser
Is Organogenesis Holdings Inc. stock attractive for income investorsMarket Movers & Technical Buy Zone Confirmation - Newser
Organogenesis Holdings Inc. (NASDAQ:ORGO) Surges 29% Yet Its Low P/S Is No Reason For Excitement - 富途牛牛
What makes Organogenesis Holdings Inc. (2PQ) stock appealing to growth investorsPortfolio Update Summary & Reliable Intraday Trade Plans - Newser
Take off with Organogenesis Holdings Inc (ORGO): Get ready for trading - Setenews
How Organogenesis Holdings Inc. (2PQ) stock reacts to monetary easingWeekly Profit Report & Weekly Breakout Opportunity Watchlist - Newser
Published on: 2025-12-02 06:45:13 - Newser
Why Organogenesis Holdings Inc. stock attracts high net worth investors2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
How dovish Fed policy supports Organogenesis Holdings Inc. (2PQ) stockTrend Reversal & Verified Trade Idea Suggestions - Newser
Organogenesis Holdings (ORGO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Have Organogenesis Holdings Insiders Been Selling Stock? - simplywall.st
Organogenesis Holdings Insider Sold Shares Worth $1,592,120, According to a Recent SEC Filing - marketscreener.com
Glenn Nussdorf Sells 100,000 Shares of Organogenesis (NASDAQ:ORGO) Stock - MarketBeat
Organogenesis director Nussdorf sells $1.59 million in shares By Investing.com - Investing.com Australia
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Shares Bounce 27% But Its Business Still Trails The Industry - simplywall.st
Glenn Nussdorf Sells 187,957 Shares of Organogenesis (NASDAQ:ORGO) Stock - MarketBeat
Organogenesis director Nussdorf sells $1.59 million in shares - Investing.com
Dir Nussdorf Sells 300,000 ($1.6M) Of Organogenesis Holdings Inc [ORGO] - TradingView
An analyst sees good growth prospects for Organogenesis Holdings Inc (ORGO) - Setenews
Dir Nussdorf Files To Sell 200,000 Of Organogenesis Holdings Inc [ORGO] - TradingView
Organogenesis (NASDAQ:ORGO) Trading Down 3.3%Here's What Happened - MarketBeat
Dir Nussdorf Files To Sell 100,000 Of Organogenesis Holdings Inc [ORGO] - TradingView
Organogenesis (NASDAQ:ORGO) Price Target Raised to $9.00 - Defense World
Organogenesis Holdings (NASDAQ:ORGO) pulls back 8.4% this week, but still delivers shareholders solid 26% CAGR over 3 years - Yahoo Finance
Organogenesis Holdings (NASDAQ:ORGO) pulls back 8.4% this week, but still delivers shareholders splendid 26% CAGR over 3 years - simplywall.st
Organogenesis (NASDAQ:ORGO) Trading Up 6.2% After Analyst Upgrade - Defense World
Organogenesis Holdings Inc.Class A (NQ: ORGO - Markets Financial Content
Is Organogenesis Holdings Inc. (2PQ) stock supported by strong fundamentalsPortfolio Profit Report & Weekly Stock Performance Updates - newser.com
Organogenesis stock price target raised to $9 by BTIG on reimbursement changes - Investing.com South Africa
Global Wound Healing Devices Market Poised for Robust Growth at a CAGR of ~5% by 2032, Driven by Rising Chronic Wound Burden | DelveInsight - GlobeNewswire Inc.
Can Organogenesis Holdings Inc. stock surprise with earnings upsideJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock attract more institutional investorsQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock supported by free cash flowWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock maintain dividend yieldPortfolio Risk Summary & Low Risk Entry Point Tips - newser.com
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Organogenesis Holdings Inc 주식 (ORGO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| NUSSDORF GLENN H | Director |
Nov 24 '25 |
Sale |
5.34 |
100,000 |
534,000 |
2,965,591 |
| NUSSDORF GLENN H | Director |
Nov 25 '25 |
Sale |
5.30 |
12,043 |
63,828 |
2,953,548 |
3.98%
자본화:
|
볼륨(24시간):